Position in LQDA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$21,256,413
+$9,183,258 QoQ
Shares Held
563,233
+60.9% QoQ
Ownership
0.633%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 98.2245358492844.ToString("F0")%
Shared 0.ToString("F0")%
None 1.775464150715601.ToString("F0")%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $750,878,580 across 46 Drug Manufacturers - Specialty & Generic names. LQDA ranks #5 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
3,060,570 | $403,199,491 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
6,392,628 | $60,857,818 | |
| 3 | ALKS |
Alkermes plc.
|
780,683 | $27,604,950 | |
| 4 | ESPR |
Esperion Therapeutics, Inc.
|
9,458,779 | $25,917,054 | |
| 5 | LQDA |
Liquidia Corp
This page
|
563,233 | $21,256,413 | |
| 6 | IRWD |
Ironwood Pharmaceuticals Inc
|
5,848,276 | $20,527,448 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
420,914 | $20,267,009 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
590,116 | $19,515,136 |
All Filings in LQDA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,256,413 | 563,233 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $12,073,155 | 350,048 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,871,456 | 434,101 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,307,595 | 746,998 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,402,827 | 434,090 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,483,347 | 381,237 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,141,030 | 314,103 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,153,500 | 346,125 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,319,611 | 292,855 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,226,319 | 351,315 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,667,103 | 262,950 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,559,578 | 326,061 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,628,225 | 380,351 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,152,978 | 494,973 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,572,951 | 840,616 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,204,498 | 505,619 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,624,864 | 365,580 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,009,824 | 412,695 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $148,385 | 53,763 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $117,832 | 41,200 | Shares | Sole | 2021-08-16 | |
| 2020-09-30 | $947,897 | 192,662 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,173,284 | 139,345 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||